1
Q
Who is selected to have a HDR Boost?
**
A
- Fit for anasthetic
- Life expectancy > 10 years
- Intermediate -> high risk
- Histologically confirmed localised adenocarcinoma of the prostate
- Clinical stage T2-T3b, N0, M0
2
Q
What is HDR protocol?
A
- Single fraction of 15Gy followed by EBRT: 37.5Gy/15# VMAT
- Boost under GA
- EBRT 2 weeks later
RADT 716
flashcards
Decks in class (33)
# Cards
-
Cervical Cancer and Screening30
-
Staging of Cervical Cancer8
-
Male Pelvic Anatomy15
-
Female Pelvic Anatomy20
-
Gynaecological Technique and Treatment13
-
Brachytherapy4
-
Breast Cancer Anatomy, Aetiology and Epidemiology1
-
Breast Cancer Signs, Symptoms and Screening0
-
Breast Cancer Management Options8
-
Breast Cancer Management Options 223
-
Radiotherapy for Breast Cancer2
-
Colorectal Cancer - Anatomy10
-
The Stomach8
-
The Small Intestine1
-
Colorectal Cancer Staging, Grading and Spread3
-
Rectal Cancer - Signs, Symptoms and Investigations5
-
Rectal Cancer Management22
-
Anal Cancer Management10
-
Guest Speaker - Rectal and Anal24
-
Prostate Anatomy7
-
Prostate: Investigations, Diagnosis, Staging and Grading23
-
Prostate: Management Options24
-
Prostate Brachytherapy2
-
Guest Speaker - Prostate Cancer5
-
Bladder Anatomy11
-
Bladder Oncology16
-
Pathological conditions: bladder/urinary/reproductive systems24
-
Prostate Cancer RT Late Effects8
-
Cervical Cancer Management Options9
-
Chemotherapy Regimines (High risk, good PS)7
-
Chemotherapy Regimines (Low risk or low PS)5
-
Breast Cancer Radiotherapy8
-
Rectal Cancer Management Update15
